BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 8337186)

  • 1. A common set of nuclear matrix proteins in prostate cancer cells.
    Pienta KJ; Lehr JE
    Prostate; 1993; 23(1):61-7. PubMed ID: 8337186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of nuclear matrix proteins in the cancer and normal rat prostate.
    Getzenberg RH; Pienta KJ; Huang EY; Coffey DS
    Cancer Res; 1991 Dec; 51(24):6514-20. PubMed ID: 1742724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nuclear matrix proteins as biomarkers in prostate cancer.
    Leman ES; Getzenberg RH
    J Cell Biochem; 2002; 86(2):213-23. PubMed ID: 12111991
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nuclear matrix protein patterns in human benign prostatic hyperplasia and prostate cancer.
    Partin AW; Getzenberg RH; CarMichael MJ; Vindivich D; Yoo J; Epstein JI; Coffey DS
    Cancer Res; 1993 Feb; 53(4):744-6. PubMed ID: 7679049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nuclear matrix proteins in normal and breast cancer cells.
    Khanuja PS; Lehr JE; Soule HD; Gehani SK; Noto AC; Choudhury S; Chen R; Pienta KJ
    Cancer Res; 1993 Jul; 53(14):3394-8. PubMed ID: 8324750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of the nuclear matrix proteins in a transgenic mouse model for prostate cancer.
    Leman ES; Arlotti JA; Dhir R; Greenberg N; Getzenberg RH
    J Cell Biochem; 2002; 86(2):203-12. PubMed ID: 12111990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tissue specificity of the hormonal response in sex accessory tissues is associated with nuclear matrix protein patterns.
    Getzenberg RH; Coffey DS
    Mol Endocrinol; 1990 Sep; 4(9):1336-42. PubMed ID: 2233749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential nuclear matrix-intermediate filament expression in human prostate cancer in respect to benign prostatic hyperplasia.
    Alberti I; Parodi S; Barboro P; Sanna P; Nicolò G; Allera C; Patrone E; Galli S; Balbi C
    Cancer Lett; 1996 Dec; 109(1-2):193-8. PubMed ID: 9020920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Electrophoretic analysis of nuclear matrix proteins and the potential clinical applications.
    Cupo JF
    J Chromatogr; 1991 Sep; 569(1-2):389-406. PubMed ID: 1939495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nuclear matrix of human ovarian cancer cells in vitro.
    Yang L; Yam GH; Fey EG; Cheng-Chew SB; Tsao GS; Wang ZH; Chew EC
    Anticancer Res; 1998; 18(4A):2535-9. PubMed ID: 9703906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Basal cells of H-Dunning tumor are myoepithelial cells. A comparative immunohistochemical and ultrastructural study with male accessory sex glands and mammary gland.
    Aumüller G; Gröschel-Stewart U; Altmannsberger M; Mannherz HG; Steinhoff M
    Histochemistry; 1991; 95(4):341-9. PubMed ID: 2022486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nuclear shape and nuclear matrix protein composition in prostate and seminal vesicles.
    Pannek J; Lakshmanan Y; Pound CR; Lemkin PF; Epstein JI; Partin AW
    Urology; 1999 Nov; 54(5):934-9. PubMed ID: 10565764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Castration induces apoptosis in the ventral prostate but not in an androgen-sensitive prostatic adenocarcinoma in the rat.
    Brändström A; Westin P; Bergh A; Cajander S; Damber JE
    Cancer Res; 1994 Jul; 54(13):3594-601. PubMed ID: 8012987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative analysis of the nuclear proliferative index (Ki-67) in benign prostate, prostatic intraepithelial neoplasia, and prostatic carcinoma.
    Tamboli P; Amin MB; Schultz DS; Linden MD; Kubus J
    Mod Pathol; 1996 Oct; 9(10):1015-9. PubMed ID: 8902840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subcellular distribution in vivo of testosterone and salt extractability of nuclear androgen complexes in the prostate and prostatic adenocarcinoma: effect of estrogen treatment.
    Batra S; Wännman H; Alenfall J; Forsgren B
    In Vivo; 1992; 6(6):573-8. PubMed ID: 1296804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of prostate cancer growth by estramustine and etoposide: evidence for interaction at the nuclear matrix.
    Pienta KJ; Lehr JE
    J Urol; 1993 Jun; 149(6):1622-5. PubMed ID: 8501820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential expression of alpha 6 and alpha 2 very late antigen integrins in the normal, hyperplastic, and neoplastic prostate: simultaneous demonstration of cell surface receptors and their extracellular ligands.
    Bonkhoff H; Stein U; Remberger K
    Hum Pathol; 1993 Mar; 24(3):243-8. PubMed ID: 7681030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of organ site on nuclear matrix protein composition.
    Replogle-Schwab TS; Getzenberg RH; Donat TL; Pienta KJ
    J Cell Biochem; 1996 Jul; 62(1):132-41. PubMed ID: 8836882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nuclear matrix proteins in well and poorly differentiated human breast cancer cell lines.
    Samuel SK; Minish TM; Davie JR
    J Cell Biochem; 1997 Jul; 66(1):9-15. PubMed ID: 9215523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nuclear matrix proteins in human colon cancer.
    Keesee SK; Meneghini MD; Szaro RP; Wu YJ
    Proc Natl Acad Sci U S A; 1994 Mar; 91(5):1913-6. PubMed ID: 8127905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.